231 related articles for article (PubMed ID: 30719145)
1. Systemic inflammation score predicts survival in patients with intrahepatic cholangiocarcinoma undergoing curative resection.
Zhang Y; Shi SM; Yang H; Yang LX; Wang Z; Li XD; Yin D; Shi YH; Cao Y; Dai Z; Zhou J; Chen Q
J Cancer; 2019; 10(2):494-503. PubMed ID: 30719145
[TBL] [Abstract][Full Text] [Related]
2. A novel prognostic system combining carbonic anhydrase II and preoperative CA19-9 for intrahepatic cholangiocarcinoma after curative resection.
Zhang J; Huang Q; Yang Y; Zhang J; Fang X; Yang Y; Liang H; Wang W; Wang Y
Cancer; 2023 Apr; 129(7):1030-1040. PubMed ID: 36625486
[TBL] [Abstract][Full Text] [Related]
3. The combination of preoperative D-dimer and CA19-9 predicts lymph node metastasis and survival in intrahepatic cholangiocarcinoma patients after curative resection.
Chen Q; Zheng Y; Zhao H; Cai J; Wang L; Zhao J; Bi X; Li Z; Huang Z; Zhang Y; Zhou J; Wu J
Ann Transl Med; 2020 Mar; 8(5):192. PubMed ID: 32309339
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a new prognostic immune-inflammatory-nutritional score for predicting outcomes after curative resection for intrahepatic cholangiocarcinoma: A multicenter study.
Zhu J; Wang D; Liu C; Huang R; Gao F; Feng X; Lan T; Li H; Wu H
Front Immunol; 2023; 14():1165510. PubMed ID: 37063918
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of systemic inflammation score in patients with hepatocellular carcinoma after hepatectomy.
Shi S; Chen Q; Ye L; Yin D; Li X; Dai Z; He J
Oncotarget; 2017 Oct; 8(45):79366-79375. PubMed ID: 29108315
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of inflammation-based indexes for intrahepatic cholangiocarcinoma following curative resection.
Wu Y; Ren F; Chai Y; Xue Z; Shen C; Zhang X; Lv Y; Hu L
Oncol Lett; 2019 Jan; 17(1):165-174. PubMed ID: 30655752
[TBL] [Abstract][Full Text] [Related]
7. Investigating effects of preoperative inflammatory biomarkers on predicting survival outcomes of intrahepatic cholangiocarcinoma after curative resection.
Zhang Z; Zhou Y; Hu K; Huang Y
World J Surg Oncol; 2020 Oct; 18(1):272. PubMed ID: 33097053
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors and Outcomes of Early Relapse After Curative Resection of Intrahepatic Cholangiocarcinoma.
Yang H; Wang J; Li Z; Yang Y; Yang L; Zhang Y; Shi Y; Cao Y; Zhou J; Wang Z; Chen Q
Front Oncol; 2019; 9():854. PubMed ID: 31555597
[TBL] [Abstract][Full Text] [Related]
9. Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma.
Fu X; Li T; Dai Y; Li J
BMC Cancer; 2019 Jul; 19(1):721. PubMed ID: 31331297
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.
Lin ZX; Ruan DY; Li Y; Wu DH; Ma XK; Chen J; Chen ZH; Li X; Wang TT; Lin Q; Wen JY; Wu XY
World J Gastroenterol; 2015 Oct; 21(38):10898-906. PubMed ID: 26478681
[TBL] [Abstract][Full Text] [Related]
11. Prognostic efficacy of inflammation-based markers in patients with curative colorectal cancer resection.
Akgül Ö; Çetinkaya E; Yalaza M; Özden S; Tez M
World J Gastrointest Oncol; 2017 Jul; 9(7):300-307. PubMed ID: 28808503
[TBL] [Abstract][Full Text] [Related]
12. Comparative performance of inflammation-based prognostic scores in patients operated for intrahepatic cholangiocarcinoma.
Lin J; Fang T; Zhu M; Xu X; Zhang J; Zheng S; Jing C; Zhang M; Liu B; Zhang B
Cancer Manag Res; 2019; 11():9107-9119. PubMed ID: 31802940
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
[TBL] [Abstract][Full Text] [Related]
14. A prognostic systemic inflammation score (SIS) in patients with advanced intrahepatic cholangiocarcinoma.
Maßmann M; Treckmann J; Markus P; Schumacher B; Albers D; Ting S; Mende B; Roehrle J; Virchow I; Rosery V; Laue K; Zaun G; Kostbade K; Pogorzelski M; Schmid KW; Baba H; Siveke JT; Paul A; Schildhaus HU; Schuler M; Wiesweg M; Kasper S
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5085-5094. PubMed ID: 36334155
[TBL] [Abstract][Full Text] [Related]
15. Association of inflammatory biomarkers with long-term outcomes after curative surgery for mass-forming intrahepatic cholangiocarcinoma.
Ohira M; Yoshizumi T; Yugawa K; Kosai-Fujimoto Y; Inokuchi S; Motomura T; Mano Y; Toshima T; Itoh S; Harada N; Ikegami T; Soejima Y; Taketomi A; Mori M
Surg Today; 2020 Apr; 50(4):379-388. PubMed ID: 31667580
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of systemic immune-inflammation index in patients with intrahepatic cholangiocarcinoma undergoing hepatic resection.
Li H; Wang JJ; Zhang M; Ren B; Li JX; Xu L; Wu H
World J Gastrointest Oncol; 2020 Apr; 12(4):467-482. PubMed ID: 32368324
[TBL] [Abstract][Full Text] [Related]
17. Tumor Burden Score Stratifies Prognosis of Patients With Intrahepatic Cholangiocarcinoma After Hepatic Resection: A Retrospective, Multi-Institutional Study.
Li H; Liu R; Qiu H; Huang Y; Liu W; Li J; Wu H; Wang G; Li D
Front Oncol; 2022; 12():829407. PubMed ID: 35330712
[TBL] [Abstract][Full Text] [Related]
18. Impact of serum carbohydrate antigen 19-9 level on prognosis and prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma.
Yamada T; Nakanishi Y; Okamura K; Tsuchikawa T; Nakamura T; Noji T; Asano T; Tanaka K; Kurashima Y; Ebihara Y; Murakami S; Shichinohe T; Mitsuhashi T; Hirano S
J Gastroenterol Hepatol; 2018 Feb; ():. PubMed ID: 29427472
[TBL] [Abstract][Full Text] [Related]
19. Liver Tumor Markers, HALP Score, and NLR: Simple, Cost-Effective, Easily Accessible Indexes for Predicting Prognosis in ICC Patients after Surgery.
Zhang D; Zeng H; Pan Y; Zhao Y; Wang X; Chen J; Wang J; Zhang Y; Zhou Z; Xu L; Chen M; Hu D
J Pers Med; 2022 Dec; 12(12):. PubMed ID: 36556261
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Combined CA19-9 with Aspartate Aminotransferase to Lymphocyte Ratio in Patients with Intrahepatic Cholangiocarcinoma After Hepatectomy.
Qiu H; Liu C; Huang M; Shen S; Wang W
Cancer Manag Res; 2021; 13():5969-5980. PubMed ID: 34377017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
